AML1310 GIMEMA study
Showing 1 - 25 of 62
Severe Infections on Acute Myeloid Leukemia (AML) Patients
Recruiting
- AML
- Adult
- Observation
-
Civitanova Marche, Ancona, Italy
- +45 more
Dec 31, 2021
Central Nervous System Involvement in Acute Myeloid Leukemia
Recruiting
- Acute Myeloid Leukemia
- Observation of CNS involvement
-
Alessandria, Italy
- +13 more
Dec 31, 2021
Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Italy (Cytarabine, Daunorubicin, Midostaurin)
Recruiting
- Acute Myeloid Leukemia With FLT3/ITD Mutation
- Cytarabine
- +3 more
-
Bari, Italy
- +19 more
Mar 1, 2022
Acute Myeloid Leukemia (AML) Trial in Worldwide (standard combination chemo, decitabine)
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- standard combination chemotherapy
- decitabine
-
Edegem, Antwerpen, Belgium
- +52 more
Sep 13, 2022
Pregnancy in Acute Promielocitic Leukaemia Patients Treated With
Recruiting
- Acute Promyelocytic Leukemia
- Pregnancy
-
Alessandria, Italy
- +36 more
Dec 31, 2021
AML, Adult, Minimal Residual Disease Trial (MRD assessment)
Not yet recruiting
- AML, Adult
- Minimal Residual Disease
- MRD assessment
- (no location specified)
Oct 13, 2023
AML, Adult Trial (Biological characterization of AML with MECOM or atypical 3q26 rearrangements)
Not yet recruiting
- AML, Adult
- Biological characterization of AML with MECOM or atypical 3q26 rearrangements
- (no location specified)
Apr 21, 2023
Adult Philadelphia Chromosome-Positive Acute Lymphoblastic
Recruiting
- Acute Lymphoblastic Leukemia
- Dasatinib and blinatumomab
-
Bari, Italy
- +16 more
Oct 10, 2022
Unfit CLL Included in GIMEMA LLC1114 Trial Who Discontinued
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Observation
- (no location specified)
Oct 12, 2023
SALVAGE TREATMENT WITH GLOFITAMAB IN RELAPSED/REFRACTORY B-NHL:
Not yet recruiting
- B-cell Non Hodgkin Lymphoma
- +2 more
- (no location specified)
Jun 22, 2023
Unfit AML Patients Treated With Combination Venetoclax Plus
Recruiting
- Acute Myeloid Leukemia
- Venetoclax plus HMA
-
Bergamo, Italy
- +22 more
Oct 10, 2022
Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated
Completed
- Chronic Myeloid Leukaemia
-
Rionero in Vulture, Potenza, Italy
- +32 more
Oct 24, 2022
BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase
Active, not recruiting
- Chronic Phase Philadelphia Positive
- +2 more
-
Alessandria, Italy
- +55 more
Jan 4, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse, NPM1 Mutation Trial in Bologna (Venetoclax+azacitidine)
Recruiting
- Acute Myeloid Leukemia
- +2 more
-
Bologna, ItalyEMATOLOGIA- AOU Policlinico S.Orsola
Mar 1, 2022
Acute Myeloid Leukemia Trial in Firenze (Venetoclax+Decitabine)
Recruiting
- Acute Myeloid Leukemia
-
Firenze, ItalyAz. Ospedaliero - Universitaria Careggi
Jan 3, 2022
Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO
Active, not recruiting
- Acute Promyelocytic Leukemia
- QoL questionnaires
-
Ascoli Piceno, Italy
- +15 more
Feb 3, 2021
BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib
Active, not recruiting
- Chronic Myeloid Leukemia
- Dasatinib discontinuation
-
Rionero in Vulture, Potenza, Italy
- +36 more
Jan 4, 2022
Hematologic Malignancies Trial in Italy (Quality of life assessment)
Recruiting
- Hematologic Malignancies
- Quality of life assessment
-
Ancona, Italy
- +26 more
May 13, 2021
Study on the Diagnosis and Management of CLL in Italy by GIMEMA
Recruiting
- Chronic Lymphocytic Leukemia
- +2 more
-
Alessandria, Italy
- +17 more
Jan 3, 2022
Acute Myeloid Leukemia Trial in Bolzano, Castelfranco Veneto (Adrenomedullin)
Recruiting
- Acute Myeloid Leukemia
- Adrenomedullin
-
Bolzano, Italy
- +1 more
Aug 16, 2021
Chronic Lymphocytic Leukemia Treated With Idelalisib and
Completed
- Chronic Lymphocytic Leukemia
- idelalisib and rituximab
-
Cona, Ferrara, Italy
- +37 more
May 11, 2022
The Acute Promyelocytic Leukaemia Asian Consortium Project
Recruiting
- Acute Promyelocytic Leukemia
-
Hong Kong, Hong KongDepartment of Medicine, the University of Hong Kong, Queen Mary
Oct 3, 2022